SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 60.73 |
| Enterprise Value ($M) | 113.91 |
| Book Value ($M) | -41.10 |
| Book Value / Share | -4.09 |
| Price / Book | -1.48 |
| NCAV ($M) | -89.62 |
| NCAV / Share | -8.91 |
| Price / NCAV | -0.68 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.32 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.44 |
| Current Ratio | 0.51 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 82.50 |
| Assets | 131.02 |
| Liabilities | 172.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Stonepine Capital Management, LLC | 5.40 | ||
| 13G/A | Great Point Partners Llc | 9.99 | 33.29 | |
| 13G | Nantahala Capital Management, LLC | |||
| 13G/A | Fmr Llc | 12.21 | 11.16 | |
| 13G/A | Rosalind Advisors, Inc. | 5.50 | 9.81 | |
| 13G/A | Acorn Bioventures, L.p. | 9.90 | 5.92 | |
| 13G/A | Kruttschnitt Theodore H Iii | 7.98 | 5.49 | |
| 13G/A | Avista Capital Partners II GP, LLC | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| , 202 | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,585 | 7,406 | 34.90 | |
| 1,783 | 18,072 | 9.87 | |
| 4,594 | 12,629 | 36.38 | |
| 1,423 | 9,171 | 15.52 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OLMA – Olema Pharmaceuticals, Inc. | OMGA – Omega Therapeutics, Inc. |
| OPK – OPKO Health, Inc. | ORIC – ORIC Pharmaceuticals, Inc. |
| OVID – Ovid Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io